Hepatitis C Journal Articles

• Patient-reported Outcomes in Real-world Patients With HCV This study aimed to describe the real-world patient-reported outcomes of patients with HCV as compared with those reported by HCV patients who were enrolled in clinical trials. How do they differ?
  Journal of Viral Hepatitis, November 23, 2022
• Safety of Glecaprevir/Pibrentasvir in Advanced Liver Disease This study examined the safety of glecaprevir/pibrentasvir treatment in patients with compensated cirrhosis with markers of advanced liver disease.
  Journal of Viral Hepatitis, November 14, 2022
• Hepatitis of Unknown Origin in Children: Updated Evidence What might be the etiology of the rapid increase of hepatitis in previously healthy children in Europe and the US? This article summarizes what little we currently know.
  Journal of Viral Hepatitis, November 09, 2022
• HIV and Associated Behaviors Among People Who Inject Drugs This article provides insight into the prevalence of HIV and risk behaviors among people who inject drugs in these regions. How have things changed over the past four decades?
  HIV Medicine, October 27, 2022
• Fluorescence Imaging to Detect Elevated Bacterial Loads Learn how a fluorescence imaging device can help optimize the care of inpatient complex wounds.
  Wounds, October 19, 2022
• Use of Statins After Liver Transplantation This study investigated whether statin use after liver transplantation reduces adverse outcomes, including re-transplant, severe and recurrent biliary-vascular complications, and death.
  Alimentary Pharmacology & Therapeutics, October 17, 2022
• Risk Factors for HCV Infection at a Large Urban ED This study aimed to identify risk factors for HCV infection in an emergency department setting catering to a mixed urban and rural population.
  Journal of Viral Hepatitis, October 14, 2022
• HCC 10+ Years After Viral Eradication in Patients With HCV What risk factors are associated with hepatocellular carcinoma development 10 years or more after SVR?
  Journal of Viral Hepatitis, October 07, 2022
• Severe and Rare Infections Among Adults With Psoriasis This study found that as the severity of psoriasis increases, so does the risk of severe and rare infections.
  The British Journal of Dermatology, October 07, 2022
• IVF-ET and Mother-to-infant Transmission in Women With HBV Does in vitro fertilization-embryo transfer increase the risk of mother-to-child transmission of hepatitis B virus?
  Liver International, October 05, 2022
• Viral Hepatitis in Pregnancy This review presents a summary of the etiology and epidemiology of the five hepatitis viruses with a focus on their immunopathogenic effects in pregnancy.
  Journal of Viral Hepatitis, September 30, 2022
• Final Safety and Efficacy of an Ascites-mobilizing Pump This study investigated the safety and efficacy of an implantable device mobilizing ascites from the peritoneal cavity to the bladder in a real-world cohort with cirrhotic refractory ascites.
  Liver International, September 21, 2022
• NAFLD Fibrosis Scores Predict Liver-related HCV Complications This study evaluated the use of noninvasive fibrosis assessments for predicting liver-related complications and hepatocellular carcinoma occurrence in patients with chronic HCV receiving DAA therapy.
  Journal of Viral Hepatitis, September 20, 2022
• Universal HBV Vaccination Reduces HBV Infection and HCC This real-life cohort study of nearly 700,000 individuals reveals that universal HBV vaccination of newborns significantly reduced the prevalence of chronic HBV infection later in life.
  Alimentary Pharmacology & Therapeutics, September 14, 2022
• NAFLD and Liver Fibrosis Increase Cardiovascular Risk in HIV Are people living with HIV with NAFLD and/or liver fibrosis at a greater risk for cardiovascular disease? A new study explores the potential link.
  HIV Medicine, September 14, 2022
• Symptom Improvement: LDV/SOF vs. EBR/GZR for Chronic HCV This study found that regimens of EBR/GZR or LDV/SOF for chronic HCV had no clinically meaningful differences in improvement of symptoms and functional well-being.
  Journal of Viral Hepatitis, September 13, 2022
• Bicyclol for Idiosyncratic Acute Drug-induced Liver Injury This study evaluated different dosing regimens of the novel synthetic anti-hepatitis drug bicyclol for treating drug-induced liver injury.
  Liver International, September 13, 2022
• Hypertension in HIV Treated With INSTIs vs Other Regimens How common is hypertension among HIV patients receiving INSTI-based ART compared with those treated with other ART regimens?
  HIV Medicine, September 07, 2022
• Follow-up of Liver Test Abnormalities Detected During SARS-CoV2 Do abnormal liver function tests noted during COVID-19 persist after resolution of the acute infection?
  Journal of Viral Hepatitis, September 06, 2022
• TDF Therapy to Prevent HBV Vertical Transmission This study investigated the efficacy and safety of tenofovir disoproxil fumarate administration to prevent HBV mother-to-child transmission
  Liver International, September 06, 2022